This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Signify Health Past Earnings Performance

Past criteria checks 5/6

Key information

-53.1%

Earnings growth rate

71.4%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate18.3%
Return on equity-15.9%
Net Margin9.5%
Last Earnings Update31 Dec 2022

Recent past performance updates

Recent updates

CVS Health to offer bonds to finance purchase of Signify Health

Feb 13

Signify Health and Prospect Medical come together to deliver coordinated, high-quality care

Jan 11

Checking Signify Health Before The CVS Transaction

Dec 21

Signify expands diagnostic offering with spirometry test for lung disease

Oct 18

Signify Health jumps on report CVS in talks to acquire for about $8 billion

Sep 02

Signify Health: Cathie Wood Now Selling

Aug 15

CVS Health seeking purchase of Signify Health - WSJ

Aug 07

Signify Health: ECS Wind Down Sheds Light On Compelling Valuation

Jul 21

Signify Health Aims Higher With New CMS Terms

Mar 16

Revisiting Signify Health

Jan 09

Signify Health names Susan Yun as chief people officer

Jun 02

Revenue & Expenses Breakdown
Beta

How Signify Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:SGFY Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 22806772330
30 Sep 22784-5182850
30 Jun 22843-3382750
31 Mar 22810322580
31 Dec 21653431740
30 Sep 21786-32450
30 Jun 21741-232300
31 Mar 21659-232140
31 Dec 20451-251450
30 Sep 20550-81980
31 Dec 1950201680
31 Dec 18338-29670

Quality Earnings: SGFY has high quality earnings.

Growing Profit Margin: SGFY's current net profit margins (9.5%) are higher than last year (6.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SGFY has become profitable over the past 5 years, growing earnings by -53.1% per year.

Accelerating Growth: SGFY's earnings growth over the past year (79.2%) exceeds its 5-year average (-53.1% per year).

Earnings vs Industry: SGFY earnings growth over the past year (79.2%) exceeded the Healthcare industry -12.4%.


Return on Equity

High ROE: SGFY's Return on Equity (-15.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.